Whole Exome Sequencing Market Size, Share, Growth, Sales Revenue and Key Drivers Analysis Research Report by 2027

The Global Whole Exome Sequencing Market size is estimated to reach USD 525.74 million by 2027

NEW YORK, NEW YORK, UNITED STATES, March 18, 2022 /EINPresswire.com/ — A new report titled Global Whole Exome Sequencing Market research report has been recently published by Reports and Data that offers radically insightful information about the Whole Exome Sequencing market with 2020 as the base year and a forecast period of 2028. The report offers key statistical data such as market value, market share, sales network and distribution channels, and revenue generation. The report further classifies the Whole Exome Sequencing market into various segments and analyzes them on global and regional scale and offers details about the key factors that positively influence their revenue growth. The report also offers country-wise segmentation and growth analysis to offer a better understanding of the regional scope of the market.

Get a sample of the report @ 

The report is formulated through exhaustive primary and secondary research which is verified and validated by industry experts, research analysts, and professionals. The report aims to help readers and users improve their business performances by providing insightful data about business sphere such as recent technological development, product advancements, and adoption of strategic business steps. The report also offers extensive analysis of the competitive landscape along with business overviews, expansion plans, and strategic alliances such as mergers and acquisitions, joint ventures, collaborations, product and brand promotions, government and corporate deals, and partnerships among others.

Top Companies in the Market Include:

BGI, Ambry Genetics, Eurofins Genomics Inc., Life Technologies, Illumina, Inc., and GENEWIZ, Inc. These industry players are adopting several strategies such as acquisitions, mergers, collaborations, new product development, and capacity expansion, thereby supporting the overall growth of the market.

Increasing focus on development of vaccines to combat COVID-19 pandemic and focus on preventive medicine to mitigate future epidemics and pandemics, rising number of product approvals for drugs and therapeutics, and rapid digital transformation in the pharmaceutical and healthcare industry are some key factors expected to drive revenue growth over the forecast period. With the social distancing norms in place and growing focus on telemedicine, digital technologies were adopted at an accelerated rate allowing healthcare professionals to efficiently manage health of the patients. One of the most crucial drivers of the pharma & healthcare industry is the rapid integration of artificial intelligence in key areas such as R&D, patient care, commercialization, and drug discovery and development. It has also led to a reduction in healthcare expenditure and improved efficiency of the systems which is expected to further contribute to revenue growth of the market going ahead.

Furthermore, to offer a better understanding of the competitive landscape, an extensive SWOT analysis and Porter’s Five Forces analysis are included in the report. Along with this, feasibility analysis and investment return analysis are also covered.  The report is segmented on the basis of product types offered in the market, application spectrum, and key regions of the Whole Exome Sequencing market.

Product Outlook (Revenue, USD Million; 2017–2027)

Systems
Hiseq Series

Hiseq 2500
Hiseq 1500
Miseq
ION Torrent Platforms
ION PGM
ION Proton
Kits
DNA Fragmentation, End Repair, A-Tailing, and Size Selection Kits
Library Preparation Kits
Target Enrichment Kits
Services
Sequencing Services
Data Analysis (Bioinformatics) Services
Others

Technology Outlook (Revenue, USD Million; 2017–2027)

Sequencing by Synthesis (SBS)
ION Semiconductor Sequencing
Other Technologies
Sequencing by Ligation (SBL)
Pyrosequencing

Request a discount on the report @ 

Application Outlook (Revenue, USD Million; 2017–2027)

Diagnostics
Cancer Diagnostics
Monogenic (Mendelian) Disorders
Monogenic Types of Diabetes
Others

Common Diseases and Complex Disorders
Movement Disorders
HIV
Drug Discovery and Development
Personalized Medicine
Agriculture & Animal Research
Others

End User Outlook (Revenue, USD Million; 2017–2027)

Hospitals
Clinics
Research Centers
Academic & Government Institutes
Pharmaceutical & Biotechnology Companies
Others

Key Regions Studied in the Report:

North America (U.S., Canada, Mexico)
Europe (U.K., Italy, Germany, France, Rest of Europe)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Request a customization of the report @ 

Thank you for reading our report. To know more about the customization of the report or further query about the report, please get in touch with us. Our team will ensure the report is well suited to your requirements. 

Browse More Reports:

Cancer Stem Cell Therapeutics Market @

Cancer Biomarkers Market @

Gene Expression Market @

Phototherapy Market @

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Tushar Rajput
Reports and Data
+18008193052 ext.
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn